Potential of Combretum Indicum var. B flowers as Hepatoprotector Through Molecular Dynamic Methods
Article Sidebar
Main Article Content
Abstract
The challenge of liver disease is predominantly found in developing countries due to the use of drugs, parasites, alcohol, bacteria, and viruses. To overcome this challenge, Combretum indicum var. B plant has been identified as potential hepatoprotector. Therefore, this study aimed to screen compounds in C. indicum var. B flowers with the potential to be CYP2C9 enzyme inhibitors using pharmacophore and molecular dynamic methods. The compounds contained in the C. indicum var. B flowers were extracted and screened based on pharmacophore, drug-likeness, absorption probability, docking, and molecular dynamics. The screening results showed that there were five compounds with potential as hepatoprotector and docking obtained the ranking based on their lowest binding energies. These compounds included 6-quanolinecarboxylic acid, ellagic acid, 2-(2-thienyl)-4H-chromen-4-one, N-[4-(diethylamino)phenyl]-N'-phenylurea, and AMPA, with binding energies of -5.52, -8.93, -7.04, -6.16, and -5.54 kcal/mol, respectively. Based on the results, the most potential compound as hepatoprotector was N-[4-(diethylamino)phenyl]-N'-phenylurea.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
1. Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World J Hepatol. 2017;9(10):491–502.
2. Dalton HR, Saunders M, Woolson KL. Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history? J virus Erad. 2015;1(1):23–29.
3. Boby N, Lee EB, Abbas MA, Park NH, Lee SP, Ali MS, Lee SJ, Park SC. Ethanol-Induced Hepatotoxicity and Alcohol Metabolism Regulation by GABA-Enriched Fermented Smilax china Root Extract in Rats. Vol. 10, Foods. 2021; 1-14.
4. Ye H, Nelson LJ, Gómez Del Moral M, Martínez-Naves E, Cubero FJ. Dissecting the molecular pathophysiology of drug-induced liver injury. World J Gastroenterol. 2018;24(13):1373–1385.
5. Rashid MH, Babu D, Siraki AG. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants. Chem Biol Interact. 2021;345:109574;1-24.
6. Sadasivam N, Kim YJ, Radhakrishnan K, Kim DK. Oxidative Stress, Genomic Integrity, and Liver Diseases. Vol. 27, Molecules. 2022; 1-18.
7. Moles A, Torres S, Baulies A, Garcia-Ruiz C, Fernandez-Checa JC. Mitochondrial-Lysosomal Axis in Acetaminophen Hepatotoxicity. Front Pharmacol. 2018;9:453; 1-14.
8. Kresnamurti A, Rakhma DN, Damayanti A, Santoso SD, Restryarto E, Hadinata W, Hamid IS. AST/ALT levels, MDA, and liver histopathology of Echinometra mathaei ethanol extract on paracetamol-induced hepatotoxicity in rats. J Basic Clin Physiol Pharmacol. 2021;32(4):511–526.
9. Zarezade V, Moludi J, Mostafazadeh M, Mohammadi M, Veisi A. Antioxidant and hepatoprotective effects of Artemisia dracunculus against CCl4-induced hepatotoxicity in rats. Avicenna J phytomedicine. 2018;8(1):51–62.
10. Veith A, Moorthy B. Role Of Cytochrome P450s In The Generation And Metabolism Of Reactive Oxygen Species. Curr Opin Toxicol. 2018;7:44–51.
11. Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, Thase ME, Winokur A, Nueten VL, Manji H, Drevets WC. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA psychiatry. 2018;75(2):139–148.
12. Sini M, Nwodo OF., Alumanah EO. Hepatoprotective activity of aqueous extract of Combretum sericeum roots against paracetamol induced hepatic damage in rats. J Sci Res Stud. 2017;1;4(2):40–46.
13. Rajalingam D, Ramachandran V, Subramani P. Evaluation of hepatoprotective and antioxidant effect of Combretum albidum G. Don against CCL4 induced hepatotoxicity in rats. Int J Pharm Pharm Sci. 2016;1;8:218-223.
14. Ujowundu F, Ogugua V, Cosmas U, Nwaoguikpe R. Aqueous extract of Combretum dolichopentalum leaf - A potent inhibitor of carbon tetrachloride induced hepatotoxicity in rats. J Appl Pharm Sci. 2011;1;1:114–117.
15. Idoh K, Dosseh K, Kpatcha T, Agbonon A, Gbeassor M. Protective effect of Combretum Hypopilinum diels: Root bark extract against CCl4-Induced hepatotoxicity in wistar rats. Pharmacognosy Res. 2018;1;10:325–331.
16. Adebisi I, Ugwah-Oguejiofor C. In vivo Hepatoprotective Effect of Combretum micranthum Leave Extract. FASEB J. 2021;1;35; 1-8.
17. Adnyana IK, Tezuka Y, Banskota AH, Tran KQ, Kadota S. Three New Triterpenes from the Seeds of Combretum quadrangulare and Their Hepatoprotective Activity. J Nat Prod. 2001; 1;64(3):360–363.
18. Kumar S, Singh J, Dubey A. Evaluation Of Hepatoprotective, Antioxidant And Cardioprotective Effects Of Aerial Part Of Quisqualis Indica Linn In Rats. J Chem Heal Risks. 2020;1;07:2020; 305-321.
19. Ijoma I, Okafor C, Ajiwe V. Computational Studies of 5-methoxypsolaren as Potential Deoxyhemoglobin S Polymerization Inhibitor. Trop J Nat Prod Res. 2024;1;8:8835–8841.
20. Falodun A, Siraj R, Choudhary M. GC-MS Analysis of Insecticidal Leaf Essential Oil of Pyrenacantha staudtii Hutch and Dalz (Icacinaceae). Trop J Pharm Res. 2009;22;8(2):139–143.
21. Rahim F, Putra PP, Ismed F, Putra AE, Lucida H. Molecular Dynamics, Docking and Prediction of Absorption, Distribution, Metabolism and Excretion of Lycopene as Protein Inhibitor of Bcl2 and DNMT1. Trop J Nat Prod Res. 2023;31;7(7):3439–3444.
22. Nur S, Hanafi M, Setiawan H, Nursamsiar N, Elya B. Molecular Docking Simulation of Reported Phytochemical Compounds from Curculigo latifolia Extract on Target Proteins Related to Skin Antiaging. Trop J Nat Prod Res. 2023;1;7(11):5067–5080.
23. Hollingsworth SA, Dror RO. Molecular Dynamics Simulation for All. Neuron. 2018;99(6):1129–1143.
24. Hospital A, Goñi JR, Orozco M, Gelpí JL. Molecular dynamics simulations: advances and applications. Adv Appl Bioinform Chem. 2015;8:37–47.
25. Liu K, Watanabe E, Kokubo H. Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations. J Comput Aided Mol Des. 2017;31(2):201–211.
26. Chen DE, Willick DL, Ruckel JB, Floriano WB. Principal component analysis of binding energies for single-point mutants of hT2R16 bound to an agonist correlate with experimental mutant cell response. J Comput Biol. 2015;22(1):37–53.
27. Theken KN, Lee CR, Gong L, Caudle KE, Formea CM, Gaedigk A, Klein TE, Agúndez JAG, Grosser T. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs. Clin Pharmacol Ther. 2020;108(2):191–200.
28. Nizamuddin S, Dubey S, Singh S, Sharma S, Machha P, Thangaraj K. CYP2C9 Variations and Their Pharmacogenetic Implications Among Diverse South Asian Populations. Pharmgenomics Pers Med. 2021;14:135–147.
29. Goldwaser E, Laurent C, Lagarde N, Fabrega S, Nay L, Villoutreix BO, Jelsch C, Nicot AB, Loriot MA, Miteva MA. Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9. PLOS Comput Biol. 2022;26;18(1):e1009820; 1-13.
30. Fatani A, Baothman OS, Shash L, Abuaraki H, Zeyadi M, Hosawi S, Altayb H, Golayel AMK. Hepatoprotective effect of date palm fruit extract against doxorubicin intoxication in Wistar rats: In vivo and in silico studies. Asian Pac J Trop Biomed. 2022;23;12:357; 357-365.
31. Akhmadiev NS, Galimova AM, Akhmetova VR, Khairullina VR, Galimova RA, Agletdinov EF, Ibragimov AG, Kataev VA. Molecular Docking and Preclinical Study of Five-Membered S,S-Palladaheterocycle as Hepatoprotective Agent. Adv Pharm Bull. 2019;9(4):674–684.
32. Bolla L, Srivastava P, Ravichandiran V, Nanjappan SK. Cytochrome P450 and P-gp Mediated Herb-Drug Interactions and Molecular Docking Studies of Garcinol. Vol. 11, Membranes. 2021; 1-14.
33. Govindarasu M, Palani M, Vaiyapuri M. In Silico Docking Studies On Kaempferitrin With Diverse Inflammatory And Apoptotic Proteins Functional Approach Towards The Colon Cancer. Int J Pharm Pharm Sci. 2017;22;9:199-204.
34. Swamy K, Ramesh G, K P, Banu S, B R, Preritha H, Rajeshwari B, Ravikumar M, Shetty P, Basappa AK, Sreenivasa S. Synthesis, Characterization, PASS prediction, In-silico ADME, Molecular docking and cyclic voltammetry studies of 1, 4, 5-trisubstituted 1, 2, 3-triazole ethanone and ethanol derivatives via Metal free approach. Asian J Chem. 2020;1;32(8):1857–1864.
35. Bijak M. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism. Molecules. 2017;22(11).
36. Jishage M, Roeder RG. Regulation of hepatocyte cell cycle re-entry by RNA polymerase II-associated Gdown1. Cell Cycle. 2020;19(23):3222–3230.
37. Gillessen A, Schmidt HHJ. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Adv Ther. 2020;37(4):1279–1301.